RxDoctor Payments DataLook up a doctor →

Louis Perdue, MD

Rheumatology · Metairie, LANPI 1184838716

Payments from drug & device makers

$16,919in general payments, 2019–2025

Across 860 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • AbbVie$4K
  • Pfizer$1K
  • Johnson & Johnson$1K
  • UCB, Inc.$950
  • Novartis$782
  • plus $6K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)202$3,609
AbbVie125$3,584
Pfizer74$1,161
Johnson & Johnson51$1,030
UCB, Inc.64$950
Novartis45$782
AstraZeneca(2 entities)37$728
Mallinckrodt Hospital Products Inc.28$623
Lilly USA, LLC36$599
Radius Health, Inc.21$432
GSK24$410
ANI Pharmaceuticals, Inc.17$391
Boehringer Ingelheim19$346
E.r. Squibb & Sons, L.L.C.19$346
Hikma Pharmaceuticals USA13$247
Fresenius Kabi USA, LLC11$211
Organon11$182
Sanofi8$172
Merz North America, Inc.2$151
Genentech USA, Inc.6$109
Actelion Pharmaceuticals US, Inc.6$103
Mallinckrodt Enterprises LLC5$93
Bristol Myers Squibb4$78
Biocon Biologics Inc4$78
Teva Pharmaceuticals USA, Inc.3$56
Pharmacosmos Therapeutics Inc.2$47
Aurinia Pharma U.S., Inc.3$45
Pacira Therapeutics, Inc.2$43
Regeneron Healthcare Solutions, Inc.2$42
Fidia Pharma USA Inc.2$40
Kyowa Kirin, Inc.2$38
Sobi, Inc2$34
Sandoz2$33
Almatica Pharma LLC1$24
Kiniksa Pharmaceuticals, Ltd.1$24
Arbor Pharmaceuticals, Inc.1$14
Acella Pharmaceuticals, LLC1$13
Bioventus LLC1$13
Daiichi Sankyo Inc.1$13
Medexus Pharma, Inc.1$13
Pacira Pharmaceuticals Incorporated1$12

How this compares

$16,919 in reported general payments places this provider in the 65th percentile of 88 rheumatology providers in Louisiana.

See all rheumatology providers in Louisiana →

Medicare billing

Part B allowed, 2024
$1,203,851
Medicare patients
478
Services billed
85,288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Metairie

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →